VISIPAQUE 270
GE HEALTHCARE CANADA INC
Quick answers
Is there a shortage of VISIPAQUE 270 in Canada?
No. There is no current shortage of VISIPAQUE 270 550MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
IODIXANOL INJECTION 270
FRESENIUS KABI CANADA LTD
Other Products
VISIPAQUE 320
GE HEALTHCARE CANADA INC
IODIXANOL INJECTION 320
FRESENIUS KABI CANADA LTD
DIN
02145766
Strength
550MG
Dosage Form
Solution
Route
Intravenous Intra-Arterial
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from GE HEALTHCARE CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.